Lumpectomy Plus Tamoxifen or Anastrozole With or Without Whole Breast Irradiation in Women With Favorable Early Breast Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 2, 2007, Pages 334-340

  Pötter, Richard ^a   Gnant, Michael ^a   Kwasny, Werner ^b   Tausch, Christoph ^c   Handl Zeller, Leonore ^a   Pakisch, Brigitte ^b   Taucher, Susanne ^a   Hammer, Josef ^c   Luschin Ebengreuth, Gero ^d   Schmid, Marianne ^d   Sedlmayer, Felix ^h   Stierer, Michael ^e   Reiner, Georg ^f   Kapp, Karin ^d   Hofbauer, Friedrich ^g   Rottenfusser, Andrea ^a   Pöstlberger, Sabine ^c   Haider, Karin ^b   Draxler, Wolfgang ⁱ   Jakesz, Raimund ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Hospital Wiener Neustadt   (Austria)

^c Krankenhaus der Barmherzigen Schwestern Linz   (Austria)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e HANUSCH HOSPITAL   (Austria)

^f Regional Hospital   (Austria)

^g Hospital Oberpullendorf   (Austria)

^h St Johanns Spital   (Austria)

ⁱ ABCSG Statistics   (Austria)

Author keywords

Breast irradiation; Lumpectomy plus hormone therapy with without irradiation; Women with favorable early breast cancer

Indexed keywords

DISEASES; DRUG PRODUCTS; HEALTH HAZARDS; HORMONES; RADIOTHERAPY; SURGERY; TUMORS;

BREAST CANCER; BREAST IRRADIATION; HORMONE THERAPY; LUMPECTOMY;

ONCOLOGY;

ANASTROZOLE; ESTROGEN RECEPTOR; IRIDIUM 192; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EARLY CANCER; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; METASTASIS; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; TUMOR VOLUME; WHOLE BODY RADIATION;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NITRILES; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TAMOXIFEN; TRIAZOLES;

EID: 34247899205     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.12.045     Document Type: Article

References (21)

1. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2002) 1233-1241
2. Liljegren G., Holmberg L., Bergh J., et al., Uppsala-Örebro Breast Cancer Study Group. 10-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J Clin Oncol 17 (1999) 2326-2333
3. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366 (2005) 2087-2106
4. Fisher B., Costantino J., Redmond C., et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 320 (1989) 479-484
5. Fisher B., Bryant J., Dignam J., et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 20 (2002) 4141-4149
6. Jakesz R., Jonat W., Gnant M., et al., ABCSG and the GABG. Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years adjuvant tamoxifen: Combined results of ABCSG trial 8 and ARNO 95 trial. Lancet 366 (2005) 455-462
7. Coombes R.Ch., Hall E., Gibson L.J., et al. for the Intergroup Exemestane Study. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 350 (2004) 1081-1092
8. The Breast International Group (BIG) 1-98 Collaborative Group. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 353 (2005) 2747-2757
9. Fyles A.W., McCready D., Manchul L., et al. Tamoxifen with or without breast irradiation in women 50 yeas of age or older with early breast cancer. N Engl J Med 351 (2004) 963-970
10. Hughes K., Schnaper L., Berry D., et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351 (2004) 971-977
11. Boccardo F., Rubagotti A., Puntoni M., et al. Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: Preliminary results of the Italian Tamoxifen Anastrozole Trial. J Clin Oncol 23 (2005) 5138-5147
12. Grünberber Th., Gorlitzer M., Solman Th., et al. It is possible to omit postoperative irradiation in a highly selected group of elderly breast cancer patients. Breast Cancer Res Treatment 50 (1998) 37-46
13. Pocock S.J., and Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 31 (1975) 103-115
14. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
15. Peto R., and Peto J. Asymptotically efficient rank invariant procedures. J R Stat Soc 135 (1972) 185-207
16. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50 (1966) 163-170
17. Cox D.R. Regression models and life tables. J R Stat Soc 34 (1972) 187-220
18. Fisher B., Jeong J.-H., Anderson S., Bryant J., Fisher E.R., and Wolmark N. Twenty-five-year follow-up of a randomized trail comparing radical mastectomy, total mastectomy and total mastectomy followed by irradiation. N Engl J Med 347 (2002) 567-575
19. Clark R.M., Whelan T., Levine M., et al., Ontario Clinical Oncology Group. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: An update. J Natl Cancer Inst 88 (1996) 1659-1664
20. Kuske R.R., Winter K., Arthur D.W., et al. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: Toxicity analysis of RTOG 95-17. Int J Radiat Oncol Biol Phys 65 (2006) 45-51
21. Ott O.J., Hildebrandt G., Pötter R., et al. Accelerated partial breast irradiation with multi-catheter brachytherapy: Local control, side effects and cosmetic outcome for 274 patients. Interim results of the German-Austrian multi-centre trial. Radiother Oncol (2006) Nov 24 [Epub ahead of print]